Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
USP And Dexcel Pick Up Teva OTC Brands
Israeli Firm Makes Divestments In Poland And UK In Line With 'Pivot To Growth' Strategy
Jan 31 2024
•
By
Tom Gallen
and
David Ridley
USP And Dexcel Have Acquired OTC Brands From Teva • Source: Shutterstock
More from Deals
More from Business